“This agreement represents a major step in the use of this innovative medical device intended to improve the method of preparation and injection of sophisticated pharmaceutical compounds not available in liquid form,” said Frederic Neftel, MD, President and CEO of Debiotech. “The selection of Clip’n’Ject by Watson Pharmaceuticals is an indication of the potential for Clip’n’Ject use for many of the biotechnology drugs presently under development.”
The Clip'n'Ject device is intended to facilitate the reconstitution and delivery of lyophilized drugs. The system consists of a plastic connector that links a prefilled diluent syringe with a standard drug vial. The diluent syringe is available in 1mL, 3mL or 5mL fill sizes. West provides the product in a single thermo-formed tray secured with a Tyvek® lid. The sealed Clip'n'Ject is terminally sterilized by ethylene oxide.
Developed by Debiotech and licensed to West Pharmaceutical Services, the Clip’N’Ject is manufactured by West Pharmaceutical Services in its facility in Montgomery, Pennsylvania.
About Debiotech SA
Debiotech S.A. specializes in the research and development of innovative medical devices in the field of drug delivery systems, drug eluting stents, electronic infusion systems, dialysis, diagnostics and imaging devices, implantable drug delivery systems and micro-systems for insulin and peptide drug delivery. www.debiotech.com. Debiotech has numerous exclusive collaboration agreements with leading companies in the medical device and pharmaceutical fields.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. (NYSE: WST - news) supports global pharmaceutical and healthcare markets with products and services that enhance the effective administration of pharmaceutical and healthcare products. West Pharmaceutical Services' technologies include drug formulation research and development, clinical research and laboratory services and the design, development and manufacture of components and systems for dispensing and delivering pharmaceutical, healthcare and consumer products.
For more information, visit West Pharmaceutical Services at www.clipnject.com and www.westpharma.com.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watsonpharm.com.
Clip'n'Ject (TM) is a trademark of West Pharmaceutical Services, Inc. TRELSTAR® is a trademark of Watson Laboratories, Inc. Tyvek® is a registered trademark of E.I. du Pont de Nemours and Company.
Avenue de Sevelin, 28
CH-1004 Lausanne, Switzerland